Baseline and Post-Treatment Serum Cytokine Levels in Each Investigational Group. حسب Káryta Suely Macêdo Martins (22404155)

الموضوعات:

Baseline and Post-Treatment Serum Levels of NT-proBNP in Each Investigational Group. حسب Káryta Suely Macêdo Martins (22404155)

الموضوعات:

Variables obtained from the SF-36 quality of life questionnaire in each experimental group. حسب Káryta Suely Macêdo Martins (22404155)

الموضوعات:

Line graph showing the values of myocardial perfusion defects in the study groups. p = ANOVA Mixed Models. حسب Káryta Suely Macêdo Martins (22404155)

الموضوعات:

Decomposition analysis of the changes in prevalence (A), DALYs (B), and mortality (C) rates of IBD among women across global, 5 SDI and 21 GBD regions. حسب Jiefeng Zhao (9090305)

الموضوعات:

Health inequalities in the burden of IBD among WCBA. حسب Jiefeng Zhao (9090305)

الموضوعات:

Estimated prevalence (A), DALYs (B), and mortality (C) rates for IBD among WCBA by 2040. حسب Jiefeng Zhao (9090305)

الموضوعات:

The global changes of AS prevalence, DALYs, and mortality rates of IBD among women from 1990 to 2021. حسب Jiefeng Zhao (9090305)

الموضوعات:

Estimated prevalence (A), DALYs (B), and mortality (C) rates of IBD in different age subgroups of WCBA by 2040. حسب Jiefeng Zhao (9090305)

الموضوعات:

The global changes of prevalence (A-C), DALYs (D-F), and mortality (G-I) rates of IBD among WCBA from 1990 to 2021. حسب Jiefeng Zhao (9090305)

الموضوعات:

Frontier analysis for the potential for improvement in reducing the burden of IBD among WCBA across 204 countries and regions. حسب Jiefeng Zhao (9090305)

الموضوعات:

Supporting information. حسب Yu Sang Choi (22656230)

"…Also, the Chao1 index for richness were remarkably decreased in both MP-treated Lep KO and WT mice, but Shannon index for evenness were increased in only MP-treated Lep KO mice. …"

This is the raw data used for this study. حسب James M. Friedman (22522150)

الموضوعات:

Pre-operative versus post-operative symptoms. حسب James M. Friedman (22522150)

الموضوعات:

The Human Disharmony Loop (full) Including Inciting Factors. حسب James M. Friedman (22522150)

الموضوعات:

Baseline Severity of Disease by Scapular Dyskinesia Stage^1. حسب James M. Friedman (22522150)

الموضوعات:

The Human Disharmony Loop Clinical Presentation. حسب James M. Friedman (22522150)

الموضوعات:

Patient Demographics. حسب James M. Friedman (22522150)

الموضوعات:

Pain and Function Outcomes Following PM Tenotomy. حسب James M. Friedman (22522150)

الموضوعات:

Diagnostic Criteria for Human Disharmony Loop. حسب James M. Friedman (22522150)

الموضوعات: